OPPOSITE EFFECTS ON HIPPOCAMPAL CORTICOSTEROID RECEPTORS INDUCED BY STIMULATION OF BETA-NORADRENERGIC AND ALPHA-1-NORADRENERGIC RECEPTORS

Citation
M. Kabbaj et al., OPPOSITE EFFECTS ON HIPPOCAMPAL CORTICOSTEROID RECEPTORS INDUCED BY STIMULATION OF BETA-NORADRENERGIC AND ALPHA-1-NORADRENERGIC RECEPTORS, Neuroscience, 66(3), 1995, pp. 539-545
Citations number
56
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03064522
Volume
66
Issue
3
Year of publication
1995
Pages
539 - 545
Database
ISI
SICI code
0306-4522(1995)66:3<539:OEOHCR>2.0.ZU;2-A
Abstract
Central corticosteroid receptors play an important role in the regulat ion of the secretion of corticosterone. Although these receptors are t hought to be regulated by circulating levels of corticosterone, there is evidence for direct neural control. For example, it has been shown that noradrenergic lesions can both increase and decrease corticostero id receptors depending on the brain structure involved. In the present study, we investigated the role of different noradrenergic receptors in the rat, by examining the effect of the acute administration of ago nists and antagonists of beta and alpha(1) noradrenergic receptors on hippocampal type I and type II corticosteroid receptor levels. The eff ects of these drugs were studied in adrenalectomized animals whose pla sma levels of corticosterone were maintained in the physiological rang e by implantation of corticosterone pellets. Our results show that the beta receptor agonist salbutamol (5 mg/kg) increased the number of ty pe I and type II hippocampal corticosteroid receptors. This effect was blocked by the beta receptor antagonist propranolol (5 mg/kg), which had no effect on its own. In contrast, the alpha(1) receptor agonist p henylephrine (100 mu g) reduced the number of type I and type II corti costeroid receptors, whereas the alpha(1) receptor antagonist prazosin (0.5 mg/kg) increased type I receptors. The effect of prazosin was at tributed to an increase in the relative beta tonus resulting from bloc kade of alpha(1) receptors. Its effect was reversed by the simultaneou s injection of the beta receptor antagonist propranolol. In conclusion , our results show that noradrenergic transmission can have both a fac ilitatory and an inhibitory action on central corticosteroid receptors by acting respectively on beta and alpha(1) noradrenergic receptors. Since noradrenergic neurons and the hypothalamo-pituitary-adrenal axis are known to be involved in various psychopathological conditions, th ese results may be relevant to treatment for dysregulation of corticos terone secretion.